Elevation Oncology, Inc. (a Delaware corporation) 17,810,000 Shares of Common Stock Pre-funded Warrants to Purchase 4,440,000 Shares of Common Stock and Common Warrants to Purchase 22,250,000 Shares of Common Stock UNDERWRITING AGREEMENTUnderwriting Agreement • June 9th, 2023 • Elevation Oncology, Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledJune 9th, 2023 Company Industry Jurisdiction
PRE-FUNDED COMMON STOCK PURCHASE WARRANT ELEVATION ONCOLOGY, INC.Elevation Oncology, Inc. • June 9th, 2023 • Biological products, (no disgnostic substances) • New York
Company FiledJune 9th, 2023 Industry JurisdictionTHIS PRE-FUNDED COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, [_____________] or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and until 5:00 p.m. (New York City time) until this Warrant is exercised in full (the “Termination Date”) but not thereafter, to subscribe for and purchase from Elevation Oncology, Inc., a Delaware corporation (the “Company”), up to [______] shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
COMMON STOCK PURCHASE WARRANT ELEVATION ONCOLOGY, INC.Common Stock Purchase Warrant • June 9th, 2023 • Elevation Oncology, Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledJune 9th, 2023 Company Industry JurisdictionTHIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, [_____________] or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and until 5:00 p.m. (New York City time) on June [13], 2028 (the “Termination Date”) but not thereafter, to subscribe for and purchase from Elevation Oncology, Inc., a Delaware corporation (the “Company”), up to [______] shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).